Results 71 to 80 of about 18,470 (171)

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant

open access: yesViruses, 2017
Smallpox vaccination carries a high risk of adverse events in recipients with a variety of contra-indications for live vaccines. Although alternative non-replicating vaccines have been described in the form of replication-deficient vaccine viruses, DNA ...
Sarah Reeman   +4 more
doaj   +1 more source

Exploring monkeypox virus antibody levels: insights from human immunological research

open access: yesVirology Journal
Monkeypox(mpox) is a zoonotic disease caused by the monkeypox virus (MPXV), which was previously endemic to West and Central Africa. However, it has recently appeared in several non-endemic countries beyond Africa.
Jing Wu, Xiaomin Zhang
doaj   +1 more source

Frequency of adverse events after vaccination with different vaccinia strains.

open access: yesPLoS Medicine, 2006
BackgroundLarge quantities of smallpox vaccine have been stockpiled to protect entire nations against a possible reintroduction of smallpox. Planning for an appropriate use of these stockpiled vaccines in response to a smallpox outbreak requires a ...
Mirjam Kretzschmar   +4 more
doaj   +1 more source

Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults. [PDF]

open access: yesEmerg Infect Dis, 2023
Sanz-Muñoz I   +9 more
europepmc   +1 more source

Old stories, new cases. Viral infectious diseases and children's health

open access: yesGlobal Pediatrics
During the 20th century, smallpox has produced between 300–and 500 million victims. In 1796, Edward Jenner conducted one of the first modern immunizations when he inoculated an 8-year-old boy using material from a cowpox lesion.
YILDIZ CAMCIOGLU
doaj   +1 more source

Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak. [PDF]

open access: yesEmerg Infect Dis, 2022
Turner M   +5 more
europepmc   +1 more source

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. [PDF]

open access: yesHum Vaccin Immunother, 2023
Tomita N   +11 more
europepmc   +1 more source

Smallpox Vaccination [PDF]

open access: yesAmerican Journal of Public Health, 1972
openaire   +2 more sources

Home - About - Disclaimer - Privacy